Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
0.6610
+0.0008 (0.12%)
At close: Nov 18, 2026, 4:00 PM EST
0.6702
+0.0092 (1.39%)
Pre-market: Nov 19, 2026, 4:29 AM EST
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $40.93 million as of November 18, 2026. It is the 31,142nd most valuable company in the world and the 4,666th biggest in the United States. Its market cap has decreased by 59.63% in one year.
Market Cap
40.93M
Enterprise Value
-72.37M
1-Year Change
-59.63%
Global Rank
Country Rank
#4,666 United States
Category
ChartMarket Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $40.93M, a decrease of -94.45%. That is a compound annual growth rate of -36.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 40.93M | -45.40% |
| Dec 31, 2025 | 74.97M | -90.65% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Annovis Bio | 46.52M |
| RenovoRx | 46.07M |
| iBio, Inc. | 45.45M |
| MindWalk Holdings | 44.18M |
| Oncolytics Biotech | 43.34M |
| Impact BioMedical | 42.42M |
| Elicio Therapeutics | 41.89M |
| Gain Therapeutics | 41.03M |